All Articles
Lynch syndrome is a hereditary genetic abnormality that can cause several types of cancer. Wenora Johnson discovered that it ran in her family after she had treatment for colon cancer. Knowing that she was at a high risk for certain cancers, and having 2 children already, she had her ovaries and uterus removed, as prevention. Read More ›
Long-term results of a pivotal trial of acalabrutinib verify that it is effective and safe as first-line therapy for patients with chronic lymphocytic leukemia. Read More ›
According to findings from a large clinical trial, the combination of ibrutinib and ublituximab is effective in treating patients with chronic lymphocytic leukemia. Read More ›
The ASCEND trial confirmed that acalabrutinib, a next-generation targeted treatment, is more effective than traditional chemoimmunotherapy in patients with relapsed chronic lymphocytic leukemia. Read More ›
Recently reported data show that fixed-duration treatment with venetoclax and obinutuzumab for 12 months is effective and tolerable in some patients with chronic lymphocytic leukemia. Read More ›
Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who require systemic therapy have a new chemotherapy-free combination regimen to consider. Read More ›
Simply put, knowledge is power. This is what you need to know about your diagnosis to become empowered. Read More ›
We are all now living in the land of uncertainty, and many patients with cancer have had their treatment plans interrupted. Breast cancer survivor and CONQUER magazine’s Editor-in-Chief Lillie E. Shockney looks at how COVID-19 may affect patients dealing with cancer these days. Read More ›
Clinical trials can offer patients an investigational drug not yet widely available. Here’s what you need to know. Read More ›
An encouraging story of survival from a breast cancer nurse navigator who is also a breast cancer survivor. Read More ›